Detalhe da pesquisa
1.
Immune checkpoint therapy-current perspectives and future directions.
Cell
; 186(8): 1652-1669, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059068
2.
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype.
J Immunol
; 202(6): 1674-1679, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728209
3.
Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells.
Cytokine
; 125: 154822, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470365
4.
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation.
J Immunol
; 200(4): 1255-1260, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330322
5.
Histone Lactylation Drives CD8 T Cell Metabolism and Function.
bioRxiv
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854142
6.
Myeloid cell-targeted therapies for solid tumours.
Nat Rev Immunol
; 23(2): 106-120, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697799
7.
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.
Viruses
; 15(2)2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851762
8.
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade.
Nat Cancer
; 4(10): 1455-1473, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653141
9.
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
Mayo Clin Proc Innov Qual Outcomes
; 6(6): 511-524, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117954
10.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Nat Commun
; 13(1): 383, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046397
11.
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9.
J Med Chem
; 64(13): 9279-9301, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142551
12.
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Front Immunol
; 12: 738093, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777349
13.
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist.
J Med Chem
; 63(9): 4776-4789, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302115
14.
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Front Immunol
; 10: 1878, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440253
15.
Activity-guided development of potent and selective toll-like receptor 9 antagonists.
Eur J Med Chem
; 159: 187-205, 2018 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30292896
16.
Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation.
Diabetes
; 65(11): 3440-3452, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561727